HCG stimulation test in children with abnormal sexual development

Insights

The human chorionic gonadotropin (HCG) test effectively assesses testosterone levels in children with disorders of sexual development. A 3-day HCG stimulation test is as reliable as a 5-day test for evaluating testosterone response.

Area of Science:

  • Pediatric Endocrinology
  • Reproductive Medicine
  • Clinical Chemistry

Background:

  • Disorders of sexual development (DSD) require accurate assessment of testicular function.
  • Plasma testosterone levels are a key indicator of Leydig cell function.
  • Human chorionic gonadotropin (HCG) stimulation is a standard method to assess the testosterone production capacity of testes.

Purpose of the Study:

  • To evaluate the efficacy of HCG stimulation for assessing plasma testosterone levels in children with DSD.
  • To compare the diagnostic utility of a 3-day versus a 5-day HCG stimulation protocol.
  • To analyze testosterone response patterns in various DSD conditions.

Main Methods:

  • Radioimmunoassay was used to measure plasma testosterone levels.
  • Sixty children with DSD underwent HCG stimulation testing.
  • A subset of 21 children had their testosterone levels compared after 3 and 5 days of HCG injections.

Main Results:

  • A strong correlation (r=0.93) was observed between 3-day and 5-day HCG tests, indicating no significant advantage of the longer protocol.
  • Boys with normal genital development showed a testosterone increment of 2.0-8.5 nmol/L after 3 HCG injections.
  • Children with anorchia exhibited a minimal response, while those with other DSDs (micropenis, cryptorchidism, hermaphroditism, etc.) displayed variable testosterone responses to HCG.

Conclusions:

  • The 3-day HCG stimulation test is a reliable and efficient method for evaluating testosterone production in children with DSD.
  • HCG testing can aid in diagnosing conditions like anorchia and assessing testicular function in diverse DSD presentations.
  • This study supports the use of shorter HCG protocols for testosterone assessment in pediatric DSD evaluations.